FDA Approves First Vaccine for Dengue, With Restrictions FDA Approves First Vaccine for Dengue, With Restrictions

Dengvaxia is for the prevention of dengue disease caused by all dengue virus serotypes in people aged 9 to 16 years who have previously had laboratory-confirmed dengue infection and who live in endemic areas.FDA Approvals
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Infectious Diseases News Alert Source Type: news